about
Botulinum toxin type B for cervical dystoniaBotulinum toxin type A versus anticholinergics for cervical dystoniaBotulinum toxin type A therapy for cervical dystoniaBotulinum toxin type B for cervical dystoniaBotulinum toxin type A versus botulinum toxin type B for cervical dystoniaMutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesisPain in Neurodegenerative Disease: Current Knowledge and Future PerspectivesClinical and genetic features of cervical dystonia in a large multicenter cohortThe phenomenology and natural history of idiopathic lower cranial dystonia.Meige syndrome: What's in a name?Role of Gα(olf) in familial and sporadic adult-onset primary dystoniaNeural correlates of abnormal sensory discrimination in laryngeal dystonia.A loud auditory stimulus overcomes voluntary movement limitation in cervical dystonia.Tremulous cervical dystonia is likely to be familial: clinical characteristics of a large cohort.High-throughput mutational analysis of TOR1A in primary dystoniaNovel THAP1 sequence variants in primary dystonia.Clustering of dystonia in some pedigrees with autosomal dominant essential tremor suggests the existence of a distinct subtype of essential tremor.Sex prevalence of focal dystonias.Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy)Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE)Nociceptive pathway function is normal in cervical dystonia: a study using laser-evoked potentials.Diagnosis of dystonic syndromes--a new eight-question approach.Phenomenology and classification of dystonia: a consensus update.Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study.Botulinum toxin therapy for cervical dystonia: the science of dosingEssential tremor: a heterogenous disorder.Cervical dystonia: effectiveness of a standardized physical therapy program; study design and protocol of a single blind randomized controlled trial.Genetic evidence for an association of the TOR1A locus with segmental/focal dystonia.Structural brain abnormalities in cervical dystoniaA retrospective study to assess resource utilization in patients with cervical dystonia in the United Kingdom.Dysport and Botox at a ratio of 2.5:1 units in cervical dystonia: a double-blind, randomized study.The autosomal dominant dystonias.Pattern of premature degenerative changes of the cervical spine in patients with spasmodic torticollis and the impact on the outcome of selective peripheral denervationHealth related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystoniaWhat are the determinants of quality of life in people with cervical dystonia?A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteinsPatient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A.Exploring factors related to physical activity in cervical dystonia.Botulinum toxin A for the treatment of cervical dystonia.Mutations in CIZ1 cause adult onset primary cervical dystonia.
P2860
Q24185766-4C97C84E-0DA0-406D-93E5-97553F1664D1Q24244910-BA5760DE-9312-489F-BE18-192873439F13Q24244957-90F00A21-782C-488F-8E2D-1D646F4E4899Q24245929-0D3573A2-8266-4BF2-BC50-794148CA7A95Q24248054-EAAF1C62-6567-4F58-8E9D-7219766CB084Q24602504-6EA4DD3B-DEA9-4E7E-A782-4ACBE75ADD1DQ26745618-723E5334-1A4E-4865-A6AE-24DDAFCD754BQ27312339-7C18F3AA-673D-4A8C-82B7-832D1D2EE556Q27321109-2176DC50-0696-45FF-8D10-96E088574E1BQ27489607-9B8947A6-C90C-42FA-8823-08089BDD7AF2Q28689107-8682AB55-41B2-4F14-9582-2D869F865227Q30395648-AA411595-7642-458D-82CE-5AB466EA5EA6Q30462341-0D05F9D5-0580-49F5-B944-9FE9B491C21BQ30592916-4B267093-673E-4C0A-B19E-6CFAE50B6093Q33417896-62A6A1E0-DE73-46F5-921E-43D05887B0A9Q33601311-E4B98947-D9C7-44FC-9D8B-9FEBB5A79AECQ33644956-407B3F2E-2B6E-4419-9AA5-9B25C5A7C984Q33734984-327BEB45-C7A7-4276-9883-87FDB4887F59Q33901413-F79A2FD2-EE74-4D9F-8EA3-CEBBC943967CQ34067456-67B9596C-8DB4-43AD-8DBB-D407E7CCAA0FQ34164515-DD89494A-4E45-4148-81CE-5732A7266329Q34202236-4795ED74-EBD1-4D66-BBFD-F5D61048BC25Q34343247-2BC0F0EE-61F1-433E-B13E-3A16148C86F1Q34364973-3F8D10D6-F03B-4FEF-809A-679368C156D4Q34518731-F95C4493-B9FB-4AE6-8376-BA7814E68062Q34811926-0FC2AE84-F746-4E4A-8817-1415228018C7Q34820424-527D7085-54E8-4C50-9BA1-3D64B5309FBFQ34985270-F4EC3604-AE2C-4A02-85D8-553A40815A86Q35019139-A84E783B-0141-43EF-BC7D-70AC02BE1BEAQ35173327-284FB950-5EC3-42A4-84EA-4FD95E66B0F3Q35175351-3DCB469B-3019-4C70-BE1F-89E777096641Q35243875-25B21966-744B-4499-B1DA-087F5C7BE240Q35456036-CE2DFE63-EA73-409E-96F6-C2CAF0A6447EQ35463218-8F4768E6-B88D-4465-AA99-F7195EAD502EQ35466924-685C2D39-D02D-4DB3-8736-E1849A9200E4Q35681898-CDF1A6E5-7FEB-4F69-ACF3-E63CE4F859DCQ35694486-DDE7A6EA-5EE5-485C-868C-39884D60E5C6Q35856177-CA88DB0E-8980-46C6-9BF9-DAC28D8AF6B7Q35871899-881BDCE4-B49E-4B5C-8851-BB6B11FDCEFAQ35907284-82D45334-EA40-41D8-9F7B-090F68FE0802
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Idiopathic cervical dystonia: clinical characteristics.
@en
Idiopathic cervical dystonia: clinical characteristics.
@nl
type
label
Idiopathic cervical dystonia: clinical characteristics.
@en
Idiopathic cervical dystonia: clinical characteristics.
@nl
prefLabel
Idiopathic cervical dystonia: clinical characteristics.
@en
Idiopathic cervical dystonia: clinical characteristics.
@nl
P356
P1433
P1476
Idiopathic cervical dystonia: clinical characteristics.
@en
P304
P356
10.1002/MDS.870060206
P407
P50
P577
1991-01-01T00:00:00Z